AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3870624 — intervention group
Group type: EXPERIMENTAL
Intervention: CA membrane (Cordis Dow 3500)
Number of subjects: 0
Study 3870624 — intervention group
Group type: COMPARATOR
Intervention: CU placebo session
Number of subjects: 0
Study 30318584 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care (fluid resuscitation)
Number of subjects: 76
Study 30318584 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid boluses
Number of subjects: 76
Study 30078554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 64)
Number of subjects: 90
Study 27485050 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels at 12-20 weeks
Number of subjects: 117
Study 27485050 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels at 34-36 weeks
Number of subjects: 117
Study 27485050 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels
Number of subjects: 117
Study 26180145 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory and expiratory muscle training (IEMT)
Number of subjects: 109
Study 26180145 — intervention group
Group type: COMPARATOR
Intervention: Sham IEMT (Control)
Number of subjects: 109
Study 23106834 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial scratching
Number of subjects: 105
Study 23106834 — intervention group
Group type: COMPARATOR
Intervention: Placebo procedure
Number of subjects: 105
Study 21116072 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal protection (DP) device (Filtrap, Nipro, Japan) during primary PCI
Number of subjects: 36
Study 21116072 — intervention group
Group type: COMPARATOR
Intervention: Stenting without distal protection (non-DP group)
Number of subjects: 36
Study 18682445 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0
Study 18682445 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study 16819678 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene on zirconia (n = 15)
Number of subjects: 37
Study 16819678 — intervention group
Group type: EXPERIMENTAL
Intervention: CoCr on CoCr (n = 9)
Number of subjects: 37
Study 16819678 — intervention group
Group type: EXPERIMENTAL
Intervention: Alumina on alumina (n = 11)
Number of subjects: 37
Study 16819678 — intervention group
Group type: COMPARATOR
Intervention: Osteoarthritis control group
Number of subjects: 37
Study 12654171 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine oil (MO) 600 mg/d providing 150 mg DHA + 30 mg EPA for 6 weeks
Number of subjects: 20
Study 12654171 — intervention group
Group type: COMPARATOR
Intervention: Placebo (600 mg sunflower oil/d)
Number of subjects: 20
Study 11165585 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated umbilical venous cord blood plasma IL‐6 concentrations (≥10 pg/mL)
Number of subjects: 92
Study 11165585 — intervention group
Group type: COMPARATOR
Intervention: Normal umbilical venous cord blood plasma IL‐6 concentrations (<10 pg/mL)
Number of subjects: 92
Study 11165585 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6 as a screening test for funisitis
Number of subjects: 92
Study 9553402 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral supplementation with vitamin C, E, and beta-carotene for 21 days
Number of subjects: 0
Study 9553402 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 7997808 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue polypeptide-specific (TPS) antigen
Number of subjects: 85
Study 7997808 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 125 antigen
Number of subjects: 85
Study 7997808 — intervention group
Group type: COMPARATOR
Intervention: Combination of TPS and CA 125
Number of subjects: 85
Study 7997808 — intervention group
Group type: EXPERIMENTAL
Intervention: TPS and CA 125 during therapy and follow-up
Number of subjects: 85
Study 3041630 — intervention group
Group type: EXPERIMENTAL
Intervention: cefpimizole
Number of subjects: 116
Study 3041630 — intervention group
Group type: EXPERIMENTAL
Intervention: cefotaxime
Number of subjects: 116
Study 3041630 — intervention group
Group type: EXPERIMENTAL
Intervention: aqueous procaine penicillin G (APPG) with 1 g of oral probenecid
Number of subjects: 116
Study 30457698 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expectations
Number of subjects: 83
Study 30457698 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral expectations
Number of subjects: 83
Study 30457698 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative expectations
Number of subjects: 83
Study 28715298 — intervention group
Group type: EXPERIMENTAL
Intervention: High velocity low amplitude (HVLA) manipulation by practitioners with different seniority
Number of subjects: 20
Study 28715298 — intervention group
Group type: EXPERIMENTAL
Intervention: High velocity low amplitude (HVLA) manipulation
Number of subjects: 20
Study 25381047 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) 4 mg intravenous every 3 months for 24 months
Number of subjects: 70
Study 25381047 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLB)
Number of subjects: 70
Study 24018055 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient care (intervention)
Number of subjects: 0
Study 24018055 — intervention group
Group type: COMPARATOR
Intervention: Inpatient care (usual care)
Number of subjects: 0
Study 21291447 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicago School Readiness Project (CSRP)
Number of subjects: 602
Study 19805441 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta 1b
Number of subjects: 74
Study 19805441 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate
Number of subjects: 74
Study 16711171 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐adherent soft silicone dressing (Mepiform)
Number of subjects: 11
Study 16711171 — intervention group
Group type: COMPARATOR
Intervention: Left‐alone management (Control)
Number of subjects: 11
Study 16711171 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft silicone dressing (Mepiform)
Number of subjects: 11
Study 15658645 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongguan capsule (TGC) with Western medicine
Number of subjects: 52
Study 15658645 — intervention group
Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 52
Study 11320886 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined preoperative radiochemotherapy with hyperthermia (Radiotherapy: 5 x 1.8 Gy up to 45 Gy; Chemotherapy: 5-Fluorouracil 300-350 mg/m2/d and Leucovorin 50 mg; Hyperthermia: SIGMA 60 applicator BSD 2000 once a week).
Number of subjects: 0
Study 9400557 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ankle-arm index (AAI < or = .9) in participants without clinical CVD at baseline.
Number of subjects: 1537
Study 7942624 — intervention group
Group type: EXPERIMENTAL
Intervention: cICAM-1 concentration in acute hepatitis
Number of subjects: 135
Study 7942624 — intervention group
Group type: EXPERIMENTAL
Intervention: cICAM-1 concentration in mild chronic liver disease
Number of subjects: 135
Study 7942624 — intervention group
Group type: EXPERIMENTAL
Intervention: cICAM-1 concentration in cirrhosis
Number of subjects: 135
Study 7942624 — intervention group
Group type: COMPARATOR
Intervention: cICAM-1 concentration in extrahepatic diseases
Number of subjects: 135
Study 7942624 — intervention group
Group type: COMPARATOR
Intervention: cICAM-1 concentration in healthy blood donors
Number of subjects: 135
Study 7942624 — intervention group
Group type: EXPERIMENTAL
Intervention: Total bilirubin
Number of subjects: 135
Study 30706488 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiwifruit (two kiwifruits twice daily for 3 days)
Number of subjects: 14
Study 30706488 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiwifruit
Number of subjects: 14
Study 30706488 — intervention group
Group type: COMPARATOR
Intervention: Control (isocaloric maltodextrin, twice daily for 3 days)
Number of subjects: 14
Study 30706488 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study 29222719 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcorneal Electrical Stimulation (TES)
Number of subjects: 3
Study 27241687 — intervention group
Group type: EXPERIMENTAL
Intervention: Building Bridges to Fatherhood program
Number of subjects: 180
Study 27241687 — intervention group
Group type: COMPARATOR
Intervention: Financial literacy comparison condition
Number of subjects: 180
Study 24888429 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip group (IHG) during 1 min of coronary balloon occlusion
Number of subjects: 74
Study 24888429 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (IHT) group performing 3 months of IHT
Number of subjects: 74
Study 24888429 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise group (NEG)
Number of subjects: 74
Study 24888429 — intervention group
Group type: COMPARATOR
Intervention: Non-training group (NTG)
Number of subjects: 74
Study 22981147 — intervention group
Group type: EXPERIMENTAL
Intervention: LB80380 maleate formulation (183 mg tablet)
Number of subjects: 32
Study 22981147 — intervention group
Group type: COMPARATOR
Intervention: LB80380 free base formulation (60 and 90 mg tablets)
Number of subjects: 32
Study 20207328 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery with relaxation (GIR)
Number of subjects: 30
Study 17888191 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg kg(‐1) propofol followed by 8% sevoflurane
Number of subjects: 38
Study 17888191 — intervention group
Group type: COMPARATOR
Intervention: 8% sevoflurane alone
Number of subjects: 38
Study 17888191 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 15944536 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified N-13 ammonia model
Number of subjects: 12
Study 15944536 — intervention group
Group type: COMPARATOR
Intervention: Conventional N-13 ammonia model
Number of subjects: 12
Study 15944536 — intervention group
Group type: COMPARATOR
Intervention: O-15 water
Number of subjects: 12
Study 14649346 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg kg(‐1)
Number of subjects: 50
Study 14649346 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 1 mg kg(‐1)
Number of subjects: 50
Study 10067708 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV vaccine candidates (e.g., live preparations, DNA plasmids)
Number of subjects: 0
Study 10067708 — intervention group
Group type: EXPERIMENTAL
Intervention: General recommendations for trial design and analysis
Number of subjects: 0
Study 10067708 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical models and trial simulations
Number of subjects: 0
Study 10067708 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative methods for sample size calculations
Number of subjects: 0
Study 8612313 — intervention group
Group type: EXPERIMENTAL
Intervention: Uracil plus ftorafur (UFT) at 350 mg/m2 plus leucovorin (150 mg daily)
Number of subjects: 8
Study 2017582 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour didactic and interactive teaching session on decision analysis
Number of subjects: 68
Study 2017582 — intervention group
Group type: COMPARATOR
Intervention: 4-hour interactive session on a nondecision analysis topic
Number of subjects: 68
Study 6129143 — intervention group
Group type: COMPARATOR
Intervention: Nomifensine
Number of subjects: 12
Study 6129143 — intervention group
Group type: COMPARATOR
Intervention: HOE 8476
Number of subjects: 12
Study 6129143 — intervention group
Group type: COMPARATOR
Intervention: Clobazam
Number of subjects: 12
Study 6129143 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 12
Study 29757489 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (early discharge)
Number of subjects: 114
Study 29757489 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 114
Study 27824252 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight neuromuscular training
Number of subjects: 28
Study 24525393 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g twice daily for 12 weeks
Number of subjects: 94
Study 24525393 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 12 weeks
Number of subjects: 94
Study 22105813 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/d)
Number of subjects: 29
Study 22105813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 20484944 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of water coolers in canteens
Number of subjects: 5866
Study 17509174 — intervention group
Group type: EXPERIMENTAL
Intervention: GBV-C positive
Number of subjects: 272
Study 17509174 — intervention group
Group type: COMPARATOR
Intervention: GBV-C negative
Number of subjects: 272
Study 16126306 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy density gruel (G1)
Number of subjects: 30
Study 16126306 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy density gruel (G2)
Number of subjects: 30
Study 12116830 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified transthecal digital block
Number of subjects: 30
Study 12116830 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous digital block
Number of subjects: 30
Study 12116830 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of modified transthecal and subcutaneous digital block
Number of subjects: 30
Study 12116830 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional ring block)
Number of subjects: 30
Study 10378908 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular physical activity (supervised training, 3 times per week for 45 minutes over 6 months)
Number of subjects: 51
Study 10378908 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 51
Study 7771838 — intervention group
Group type: EXPERIMENTAL
Intervention: Open venous reservoir system (ORS)
Number of subjects: 20
Study 7771838 — intervention group
Group type: COMPARATOR
Intervention: Closed reservoir system
Number of subjects: 20
Study 2181630 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (7 days)
Number of subjects: 70
Study 2181630 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacampicillin (7 days)
Number of subjects: 70
Study 2181630 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin (7 days)
Number of subjects: 70
Study 85538 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic stimuli (tones) at 3 intensities
Number of subjects: 0
Study 85538 — intervention group
Group type: COMPARATOR
Intervention: Visual stimuli (light flashes) at 3 intensities
Number of subjects: 0
Study 85538 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic stimuli (tones) at 3 rates of presentation
Number of subjects: 0
Study 85538 — intervention group
Group type: COMPARATOR
Intervention: Visual stimuli (light flashes) at 3 rates of presentation
Number of subjects: 0
Study 31400933 — intervention group
Group type: EXPERIMENTAL
Intervention: PGC preparation
Number of subjects: 18
Study 29844209 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulizer with HFNC
Number of subjects: 6
Study 29844209 — intervention group
Group type: COMPARATOR
Intervention: Jet nebulizer
Number of subjects: 6
Study 27241835 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 frames per second (f/s)
Number of subjects: 39
Study 27241835 — intervention group
Group type: COMPARATOR
Intervention: 15 frames per second (f/s)
Number of subjects: 39
Study 24948695 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid diagnostic tests
Number of subjects: 5794
Study 24948695 — intervention group
Group type: COMPARATOR
Intervention: Clinical diagnosis
Number of subjects: 5794
Study 24948695 — intervention group
Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 5794
Study 22511495 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose imatinib (800 mg/day for 6 months) followed by standard-dose imatinib (400 mg/day)
Number of subjects: 227
Study 22511495 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose imatinib (400 mg/day)
Number of subjects: 227
Study 20547287 — intervention group
Group type: EXPERIMENTAL
Intervention: STI-positive adolescents who received treatment and counseling
Number of subjects: 636
Study 20547287 — intervention group
Group type: COMPARATOR
Intervention: STI-negative adolescents who received no further intervention
Number of subjects: 636
Study 17977537 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of ferrous sulfate daily
Number of subjects: 244
Study 17977537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 16096286 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidcombe programme of early stuttering intervention
Number of subjects: 54
Study 16096286 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 12684807 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher physical activity levels (more time in sporting activities)
Number of subjects: 256
Study 12684807 — intervention group
Group type: COMPARATOR
Intervention: Lower physical activity levels (less time in sporting activities)
Number of subjects: 256
Study 12684807 — intervention group
Group type: EXPERIMENTAL
Intervention: Active females
Number of subjects: 256
Study 12684807 — intervention group
Group type: COMPARATOR
Intervention: Hypoactive females
Number of subjects: 256
Study 12684807 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 256
Study 12684807 — intervention group
Group type: COMPARATOR
Intervention: Girls
Number of subjects: 256
Study 11374853 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy
Number of subjects: 0
Study 11374853 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal medical therapy including aggressive lipid control
Number of subjects: 0
Study 11374853 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery revascularization
Number of subjects: 0
Study 8792265 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivotal Response Training (PRT)
Number of subjects: 0
Study 8792265 — intervention group
Group type: COMPARATOR
Intervention: Individual Target Behaviors (ITB)
Number of subjects: 0
Study 1448776 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinate (recombinant FVIII preparation)
Number of subjects: 47
Study 1448776 — intervention group
Group type: COMPARATOR
Intervention: Hemofil M (high‐purity plasma‐derived concentrate)
Number of subjects: 47
Study 3893238 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium chloride
Number of subjects: 73
Study 3893238 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 73
Study 31107920 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory temporal training activities
Number of subjects: 25
Study 31107920 — intervention group
Group type: COMPARATOR
Intervention: Passive visual activities (placebo)
Number of subjects: 25
Study 28351354 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management group (met with a case manager at least three times over 12 months)
Number of subjects: 95
Study 28351354 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study 28351354 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management group
Number of subjects: 95
Study 26277934 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided Attention (DA) during encoding with semantically related distractors
Number of subjects: 0
Study 26277934 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided Attention (DA) during encoding with semantically unrelated distractors
Number of subjects: 0
Study 26277934 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided Attention (DA) during retrieval with semantically related distractors
Number of subjects: 0
Study 26277934 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided Attention (DA) during retrieval with semantically unrelated distractors
Number of subjects: 0
Study 25116967 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol ointment (3 mcg/g)
Number of subjects: 10
Study 25116967 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone diproprionate ointment (64 mg/g)
Number of subjects: 10
Study 21756141 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-hydrolized carnosine (Can-C Plus® formulation)
Number of subjects: 42
Study 21756141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 19218618 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelli‐Robson charts for contrast sensitivity measurement
Number of subjects: 107
Study 17444139 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 40
Study 17444139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15774778 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term preoperative radiotherapy (5 x 5 Gy)
Number of subjects: 990
Study 12199663 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative risk information (numerical and graphical presentation)
Number of subjects: 198
Study 12199663 — intervention group
Group type: COMPARATOR
Intervention: Qualitative risk information (verbal phrases)
Number of subjects: 198
Study 12199663 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative risk information
Number of subjects: 198
Study 12199663 — intervention group
Group type: COMPARATOR
Intervention: Qualitative risk information
Number of subjects: 198
Study 9445122 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical systematic mediastinal lymphadenectomy (LA)
Number of subjects: 169
Study 9445122 — intervention group
Group type: COMPARATOR
Intervention: Mediastinal lymph node sampling (LS)
Number of subjects: 169
Study 9445122 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical systematic mediastinal lymphadenectomy (LA) in patients with limited lymph node involvement (pN1 or pN2 with involvement of only one lymph node level)
Number of subjects: 169
Study 9445122 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical systematic mediastinal lymphadenectomy (LA) in patients with pN0 disease
Number of subjects: 169
Study 8704439 — intervention group
Group type: EXPERIMENTAL
Intervention: Longevity-Antihypertensive-Mixture (LAM)
Number of subjects: 302
Study 2234840 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon green (514 nm) modified grid laser photocoagulation
Number of subjects: 132
Study 2234840 — intervention group
Group type: COMPARATOR
Intervention: Krypton red (647 nm) modified grid laser photocoagulation
Number of subjects: 132
Study 699507 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% CO2
Number of subjects: 10
Study 699507 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% CO2
Number of subjects: 10